Axe Compute (NASDAQ: AGPU) boosts ATM share capacity to $100M
Rhea-AI Filing Summary
Axe Compute Inc. filed an 8-K describing a new prospectus supplement tied to its existing Form S-3 shelf and at-the-market stock offering program with H.C. Wainwright & Co. as sales agent. Following this supplement, the aggregate amount of shares that are available for sale under the ATM program is $100,000,000.
The company notes it is no longer subject to the offering limitations of General Instruction I.B.6 of Form S-3 and that, during the 12 calendar months up to and including the prospectus supplement date, it sold securities with an aggregate market value of approximately $12.7 million under this framework. A legal opinion from Lucosky Brookman LLP covering the ATM shares is filed as Exhibit 5.1.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 8.01, 9.01
2 items
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
ATM program capacity: $100,000,000
ATM sales last 12 months: $12.7 million
Form S-3 reference: Form S-3 (333-279123)
+2 more
5 metrics
ATM program capacity
$100,000,000
Aggregate amount of shares available for sale after prospectus supplement
ATM sales last 12 months
$12.7 million
Aggregate market value of securities sold in the 12 months up to the supplement date
Form S-3 reference
Form S-3 (333-279123)
Registration statement underlying the ATM Prospectus
ATM Sales Agreement date
May 3, 2024
Date Axe Compute entered into ATM Sales Agreement with H.C. Wainwright
Prospectus supplement date
May 15, 2026
Date of latest prospectus supplement updating ATM Prospectus
Key Terms
at the market offering, Form S-3, General Instruction I.B.6 of Form S-3, prospectus supplement, +1 more
5 terms
at the market offering financial
"to sell shares of the Company’s common stock... through an “at the market offering” program"
An at-the-market offering is a way a company raises cash by selling newly issued shares directly into the open market at prevailing prices, rather than all at once in a single deal. Think of it like turning a faucet on to drip shares into trading at current prices when needed; it gives the company flexibility to raise funds over time but can dilute existing shareholders and potentially affect the stock price, which investors should monitor.
Form S-3 regulatory
"registration statement on Form S-3 (333-279123)"
Form S-3 is a legal document companies use to register their stock sales with the government, making it easier and faster for them to raise money by selling shares to investors. It’s like having a pre-approved shopping list that lets a company quickly sell new shares when they need funds, without going through a lengthy approval process each time.
General Instruction I.B.6 of Form S-3 regulatory
"no longer subject to the offering limitations imposed by General Instruction I.B.6 of Form S-3"
prospectus supplement regulatory
"filed a prospectus supplement (the “Prospectus Supplement) to the prospectus, dated May 21, 2024"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
ATM Sales Agreement financial
"entered into an ATM Sales Agreement (the “Agreement”) on May 3, 2024"
An ATM sales agreement is a standing arrangement that lets a company sell its shares directly into the open market at prevailing prices, often through a broker, instead of selling a large block all at once. Investors care because it gives the company a flexible, on-demand way to raise cash but can slowly increase the number of shares outstanding and put downward pressure on the stock price—think of it like drip-feeding new supply into a marketplace.
FAQ
What did Axe Compute Inc. (AGPU) disclose in its latest 8-K?
Axe Compute Inc. disclosed a new prospectus supplement updating its at-the-market stock offering program under an existing Form S-3 shelf, confirming continued capacity to sell shares and attaching a supporting legal opinion from Lucosky Brookman LLP as an exhibit.
How large is Axe Compute Inc.’s at-the-market offering capacity?
Following the new prospectus supplement, Axe Compute Inc. states that the aggregate amount of shares available for sale under its at-the-market offering program is $100,000,000, providing a defined ceiling for future common stock sales through its sales agent.
How much has Axe Compute Inc. (AGPU) sold through the ATM in the past year?
Axe Compute Inc. reports that it sold securities with an aggregate market value of approximately $12.7 million during the 12 calendar months prior to, and including, the date of the latest prospectus supplement for its at-the-market stock offering program.
What change did Axe Compute Inc. report regarding Form S-3 General Instruction I.B.6?
Axe Compute Inc. indicated it is no longer subject to the offering limitations imposed by General Instruction I.B.6 of Form S-3, which previously constrained how much it could offer under the shelf registration used for its at-the-market program.
Who is the sales agent for Axe Compute Inc.’s at-the-market offering program?
H.C. Wainwright & Co., LLC acts as the sales agent for Axe Compute Inc.’s at-the-market offering program, handling sales of common stock from time to time under the existing ATM Sales Agreement and related prospectus documents.
What legal opinion did Axe Compute Inc. (AGPU) file with this 8-K?
Axe Compute Inc. filed a legal opinion from Lucosky Brookman LLP as Exhibit 5.1. The opinion addresses the shares of common stock that may be issued under the at-the-market offering program and includes the related consent within the same exhibit.
AI-generated analysis. How Rhea-AI works. Not financial advice.
